Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer Leveraging Consumer Growth From Product Launches, More Shelf Space

This article was originally published in The Tan Sheet

Executive Summary

Global consumer chief Erica Mann says OTC drug and nutritional product sales should increase during the current quarter as consumers' self-care focus turns to sunscreens and allergy treatments. Bayer plans around 30 consumer product launches later in the year.

You may also be interested in...



Bayer Consumer Health Journey Still Short Of Destination

Bayer says issues encountered after acquiring Merck & Co.’s consumer brands two years ago have meant slower growth than expected. But it suggests that’s not a precedent for its planned mega-merger with Monsanto.

Bayer Consumer Health Journey Still Short Of Destination

Bayer says issues encountered after acquiring Merck & Co.’s consumer brands two years ago have meant slower growth than expected. But it suggests that’s not a precedent for its planned mega-merger with Monsanto.

Bayer Shoulders Marketing Spend To Lift Consumer Product Sales

Headwinds for the consumer products business included support for launching ClariSpray and promoting the July introduction of Aleve Direct Therapy device for lower back pain.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS108302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel